ARCHIVES

In Brief: James Downing named CEO of St. Jude

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

In Brief: Abeloff, Fisher Lead ASCO; Henney Replaces Antman On Govt. Relations; Ultmann Retires

May 31, 1991